vimarsana.com

Latest Breaking News On - Earnings forecasts amp projections - Page 24 : vimarsana.com

Baozun Announces Second Quarter 2023 Unaudited Financial Results

/PRNewswire/ Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital.

Hong kongNew yorkUnited statesDavid beckhamArthur yuHickey freemanHunter ip holdcoAsia hunter ip holdcoVince camutoVan heusenTed bakerMuhammad aliWendy sunJudith leiberElvis presleyGreg norman

Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results

/PRNewswire/ Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically.

United kingdomJames porterPrnewswire nuvalent incNuvalent incExchange commissionCompany annual report on formChief executive officerKey anticipatedMedical meetingFourth quarterToward selectionOperating runwayPrivate securities litigation reform actAnnual reportMonths ended juneHealth care amp hospitals

Gogoro Releases Second Quarter 2023 Financial Results

/PRNewswire/ Gogoro Inc. (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities,.

T ai peiHorace lukeBruce aitkenInternational accounting standards boardInternational financial reporting standardsExchange commissionGogoro incGlobal company of the yearSecurities exchangeSecurities actSecurities exchange actConsolidated statementsMonths ended juneRucking amp railroadOil amp energyGreen technology

GoHealth Reports Second Quarter 2023 Results

/PRNewswire/ GoHealth, Inc. (NASDAQ: GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health.

United statesJason schulzGohealth incExchange commissionCommission revenueAgency revenueSecurities exchangeServices revenueTwelve monthsCommittee rejectsUnsolicited non bindingSpecial committeeGohealth boardCommon stockFull yearVijay kotte

Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

/PRNewswire/ Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and.

United statesSteven kellyLeadership teamCompany phaseVivo oncology program moderna collaborationPrnewswire carisma therapeutics incFred hutchinson cancer centerExchange commissionDrug administrationUniversity of pennsylvania abramson cancer centerCarisma therapeutics incSarah cannon cancer research instituteCity of hope national medical centerOregon health science universityCompany quarterly report on formMd anderson cancer center

vimarsana © 2020. All Rights Reserved.